<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab2">
 <label>Table 2</label>
 <caption>
  <p>Adverse cardiovascular effects of potential drugs to treat COVID-19</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Drug</th>
    <th>Mechanism of action</th>
    <th>Cardiovascular adverse effects</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td colspan="3">
     <bold>
      <italic>Inhibitors of endocytosis</italic>
     </bold>
    </td>
   </tr>
   <tr>
    <td>Camostat mesylate</td>
    <td>Inhibition of TMPRSS2</td>
    <td>Not common</td>
   </tr>
   <tr>
    <td>Chloroquine and hydroxychloroquine</td>
    <td>Blockade of virus entry by multiple mechanisms</td>
    <td>QT interval prolongation</td>
   </tr>
   <tr>
    <td>Umifenovir</td>
    <td>Inhibition of S protein–ACE2 interaction and membrane fusion</td>
    <td>Not common, but limited clinical data</td>
   </tr>
   <tr>
    <td colspan="3">
     <bold>
      <italic>Inhibitors of synthesis of non-structural proteins</italic>
     </bold>
    </td>
   </tr>
   <tr>
    <td>Lopinavir–ritonavir</td>
    <td>Inhibition of 3-chymotrypsin-like protease</td>
    <td>Atrioventricular block and cytochrome P450 3A4-related drug–drug interaction</td>
   </tr>
   <tr>
    <td colspan="3">
     <bold>
      <italic>Inhibitors of viral RNA replication</italic>
     </bold>
    </td>
   </tr>
   <tr>
    <td>Favipiravir</td>
    <td>Inhibition of RdRP</td>
    <td>Not common, but limited clinical data</td>
   </tr>
   <tr>
    <td>Remdesivir</td>
    <td>Inhibition of RdRP</td>
    <td>Not common, but limited clinical data</td>
   </tr>
   <tr>
    <td>Ribavirin</td>
    <td>Inhibition of RdRP</td>
    <td>Not common</td>
   </tr>
   <tr>
    <td colspan="3">
     <bold>
      <italic>Others</italic>
     </bold>
    </td>
   </tr>
   <tr>
    <td>Azithromycin</td>
    <td>Macrolide antibiotic; used in combination with chloroquine or hydroxychloroquine</td>
    <td>QT interval prolongation</td>
   </tr>
   <tr>
    <td>Tocilizumab</td>
    <td>IL-6 inhibition</td>
    <td>Hypertension</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>ACE2, angiotensin-converting enzyme 2; COVID-19, coronavirus disease 2019; RdRP, RNA-dependent RNA polymerase; S protein, spike protein.</p>
 </table-wrap-foot>
</table-wrap>
